Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
about
The retinoblastoma family of proteins and their regulatory functions in the mammalian cell division cycleCanine distemper virus induces apoptosis in cervical tumor derived cell linesMutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteinsSmoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinomaThe regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutationsRole of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene productHomologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteinsThe BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactionsRNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130.Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7.Gps2, a protein partner for human papillomavirus E6 proteinsInteraction of zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocationHuman papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradationThe retinoblastoma protein is phosphorylated on multiple sites by human cdc2c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activationId2 specifically alters regulation of the cell cycle by tumor suppressor proteinsDifferential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteinsViruses associated with human cancerAnalysis of p107-associated proteins: p107 associates with a form of E2F that differs from pRB-associated E2F-1Glycogen synthesis correlates with androgen-dependent growth arrest in prostate cancer.HPV Associated Head and Neck CancerThe structure and regulation of Cullin 2 based E3 ubiquitin ligases and their biological functionsThe association of mammalian DREAM complex and HPV16 E7 proteinsRegulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 OncoproteinsGenomic landscape of human papillomavirus-associated cancersMechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infectionAttenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine ApproachCrystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulationp16 protein expression and human papillomavirus status as prognostic biomarkers of nonoropharyngeal head and neck squamous cell carcinomaFunctional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical SitesModulation of therapeutic sensitivity by human papillomavirusThe binding domain structure of retinoblastoma-binding proteinsHuman papilloma virus in oral cancerViral control of mitochondrial apoptosisThe JAK-STAT transcriptional regulator, STAT-5, activates the ATM DNA damage pathway to induce HPV 31 genome amplification upon epithelial differentiationThe cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene productsMitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility
P2860
Q21203547-A0B1B510-7AE9-402E-B984-38CE5092BEE3Q21245102-075F0595-9763-43DD-AC5A-74713DE177F0Q22253968-D9841CBE-24EA-46D4-A18C-2E87614D4107Q23916001-EFD69262-C3C8-48A9-9E35-640DE2AEAD2DQ24296000-DFE0E030-AA1D-4D8B-B764-6D085953B3E3Q24309432-4E761F08-1D68-4268-B051-B45B42E48C5CQ24312129-D19CA886-41BD-403F-B055-276A7CD35548Q24323073-944D0A08-8568-4322-8C8E-55F5BBE7F7A5Q24337493-90691C01-52BA-4167-8D73-0964FAAA93FCQ24337640-C8EE9A3D-194C-45FC-A13A-A53C8E6E26D4Q24517706-E29F0838-3E9B-41CD-AFD1-8310AB6883B1Q24523723-8B1D6B70-6EB7-4B73-8FC7-D0759F1E8DA0Q24529012-77A8297F-1905-435B-8011-0A8D063390A5Q24529358-4D3CC29F-BD04-49E4-B712-E98A72AC71E1Q24537722-F1339C7B-96D5-43C2-BEF5-488B3537E40FQ24554547-042A9CC4-B9A3-4927-BBF7-2FBDA9495F6DQ24564605-5F013689-3023-4BBE-A6A7-BF0443833DAAQ24643842-214B0322-3B76-4670-AEFC-6E6F33D069E9Q24649133-9565A5BE-982B-400B-A23C-59ECE01F826DQ24651899-7382A226-914C-44B5-9185-63284B5B13F1Q24653900-F2BF84E2-64AD-43FC-8593-698979953426Q24655699-B454A7F4-EECB-46FE-8343-40C95F678C61Q24795081-274114FE-DF85-4475-9CE6-8080B802296CQ26741386-B0E2CFD1-5FF3-42B6-B5A5-37E7D38EFB34Q26746044-3F2EBF75-CB60-4997-A20A-8C53A078B76BQ26765217-76FAED40-E7D6-46C5-9484-44595006F306Q26795741-7FDAAF83-400B-43B1-A07B-D7D9318A1CD6Q26997399-2B4B68FA-DD9B-49E0-B99C-F74724DD8621Q27002467-232CA6EA-7B4D-4732-A5DA-F422B0D9A75CQ27316846-D194D814-22FA-453E-B0C3-B835D6537C3DQ27640571-6E07AA9E-6637-4759-A692-5371D98B93D2Q27853077-DA191300-CC3F-434F-82FB-FC8539ECB88CQ28078631-B6C23759-078C-438C-900D-90495BE63D7DQ28087031-2ECDAC7F-50A7-4DEA-BCD5-E9C391C91264Q28263012-82CFCED6-F610-4DE3-B964-D69A66B3DEFFQ28357079-89C5E518-F7B7-4E9C-B636-2A8E16643F51Q28472776-DA6DC11D-1114-4678-A87B-38A85FED8E42Q28485982-50F2C5F3-0C22-4E87-A442-EF740D64150EQ28508496-6188EF80-C192-4A7B-874C-001CC2158E2EQ28548371-2B1B7B15-E227-40B8-AB3E-0A60ACCB3EBE
P2860
Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.
description
1989 nî lūn-bûn
@nan
1989 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Complex formation of human pap ...... tumor suppressor gene product.
@ast
Complex formation of human pap ...... tumor suppressor gene product.
@en
Complex formation of human pap ...... tumor suppressor gene product.
@nl
type
label
Complex formation of human pap ...... tumor suppressor gene product.
@ast
Complex formation of human pap ...... tumor suppressor gene product.
@en
Complex formation of human pap ...... tumor suppressor gene product.
@nl
prefLabel
Complex formation of human pap ...... tumor suppressor gene product.
@ast
Complex formation of human pap ...... tumor suppressor gene product.
@en
Complex formation of human pap ...... tumor suppressor gene product.
@nl
P2093
P2860
P1433
P1476
Complex formation of human pap ...... tumor suppressor gene product.
@en
P2093
P2860
P304
P407
P577
1989-12-01T00:00:00Z